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INTRODUCTION:
Titanium dioxide ceramics are potentially useful s
porous cell carrier materials whose properties, such s
good permeability, serve to enhance cell vitality. In
porous materials, the exchange area is very high, which
necessitates high chemical resistance in biological media.
This condition can be met by the use of titanium dioxide
materials. Furthermore, it was demonstrated that the
biocompatibility of titanium and its alloys is associated
with the formation of a chemically stable oxide film on
thesurface [1,2].
Titanium dioxide is commercially available s fine-
grained powders with crystallite sizes below l μπι. As
this does not favour the development of porous ceramics,
a process was established to increase the grain sizes to
bet\veen 5 and 15 μπι [3]. The effect of tantalum and
tungsten oxide on grain growth was investigated. Earlier
studies revealed that tantalum oxide additions support the
formation of porous titanium dioxide ceramics [4].
Tungsten oxide was chosen s an alternative dopant s it
acts s a sintering aid.
The cytocompatibility of these materials was assessed by
culturing cells on flat samples. As most ceramic studies
have concentrated on bone cells, the osteogenic cell line
MC3T3-E1 was used. This paper describes the effect of
dififerent titanium dioxide materials on cell growth and
distribution.
MATERIALS AND METHODS:
Ceramics:
Commercial titanium dioxide powder (1171, Kronos)
was suspended in water (50 wt%). 6.52 % tantalum oxide
or 2.86 % tungsten oxide (l Mol %) respectively, were
added, ball milled, spray dried, and heated to 1300 °C
(3 K/min) for 20 min. Deagglomeration was achieved by
dry milling for l h. Small Grains (< 3μπι) and large
agglomerates were eliminated by a Sedimentation process
(Fig. 1).
10 g titanium dioxide powder was mixed with 0.6 g
graphite powder (KS 6, Lonza) and 2.8 g paraffin (MP
64 °C, Fluka) into a thermoplastic mixture. A
composition with reduced porosity was made by mixing
10 g of undoped powder with 4 g of as-delivered,
untreated powder and 1.5 g paraffin. The mixture was
heated to 100 °C andpressed into round discs of 15 mm
diameter. After a low-temperature firing cycle for polymer
bumout at 300 °C the samples were sintered at 1350 °C
for 20 min. Finishing was done by ultrasonic cleaning for
15 s and flushed with deionized water. Open porosity was
measured by cold water uptake and the material structure
was assessed by SEM (Hitachi S 2500 C).
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Figure 1: Sedimentation devicefor Separation of grain
fractions. The Suspension is pumped into the
Sedimentation tube where the coarse fraction settles in
the collector trap. Fine material is drawn into the outlet
vessel. The grain size of the fractions can be varied by
alteration ofthe pump rate.
Cytocompatibility Assays:
Cytocompatibility testing was performed using the
osteogenic cell line MC3T3-E1 (Dept. Pathophysiology,
Uni. Bern, Switzerland) cultured in oc-MEM medium
containing 5% fetal calf serum and antibiotics (all from
Gibco) at 37°C and 5% CO2. Test ceramic discs were
individually placed in wells of 24 well tissue culture
plates (Nunc), seeded at 5000 cells/well in l ml medium
and incubated with medium change every 3 days. Cells
in wells without ceramics were used s positive controls.
All determinations were carried out in triplicate.
Figure 2:
undoped,
x5000. Large
grains with
elongated mor-
phology prevai. l
Figure 3:
Ta2O5-doped,
xSOOO. Small
grain size and
open structure
areformed.
Figure 4:
WOz-doped
xSOOO. Grains
have rounded
morphology.
Proliferation of cells on ceramic samples was evaluated
with the MTT test [5]. At intervals, medium from
sample wells was replaced with 100 μΐ (5 mg/ml) MTT
(Sigma) in phosphate buffered saline (PBS) and incubated
for 1.5 h. Reduction of MTT into a colored tetraformazan
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product was determined spectroscopically (SLT
multiwell reader) at 560 nm after ethanol elution.
Cell viability and distribution on ceramic surfaces were
monitored by double fluorescent labeling using a kit
(CPAK CVO 01, Millipore) containing calcein-AM
(excitation 485 nm, emission 530 nm) and ethidium
homodimer (excitation 485 nm, emission 620 nm). At
intervals, medium from sample wells was replaced by
fluorescent reagents in l ml PBS. Cells were examined
after l h by fluorescence microscopy (Zeiss).
RESULTS:
Ceramics:
The investigated materials showed open porosities of 57-
60 % by volume. Due to the high porosity of these
compositions the surface of the samples was sensitive to
erosion during handling and testing. This behaviour was
especially marked in tantalum oxide-doped material. The
compositions with reduced porosity had a pore content of
33.2 %. It was of markedly higher strength. Undoped
material has the highest grain size of the investigated
mixtures (Fig. 2). Tantalum-doped material is
ι characterized by its small crystallite size (Fig. 3).
i Crystallite size in tungsten-doped material is smaller man
: in undoped material (Fig. 4). Tungsten doping has a
i noticeable effect on grain shape: the grains are rounded in|moφhology, whereas elongated grain shapes are more
; frequent in undoped and tantalum-doped materials.
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Figure 5: Cell viability assessed by MTT lest after 10 d
in culture. Results are given s percentages ofcontrol
Cell Assays:
The MTT assay indicated that the cytocompatibility of
control cells was approached most closely by the
titanium dioxide samples with reduced porosity, followed
by undoped samples and those doped with tungsten
oxide, both showing similar cell growth and viabilities.
Tantalum oxide-doped samples demonstrated the lowest
cell vitality (Fig. 5). Fluorescent labeling confirmed these
results and in addition, showed the cell distribution on
the ceramic samples to be patchy and uneven in
comparison to controls. Furthermore, cells on tungsten-
doped ceramic appeared to be smaller and rounder than
those on undoped samples (Figs. 6-8).
DISCUSSION:
The difierence in cell viabilities which was observed
between undoped titanium dioxide samples of high and
reduced porosities indicates that material structure plays
an important role in cytocompatibility. Considering the
low strength of the samples and consequent particle
release, it is unclear whether the low viabilities measured
for tantalum oxide-doped material were due to the
chemical composition. This was obvious in the case of
tantalum-doped material where the Inhibition of sintering
caused by doping lead to low strength. With undoped
and tungsten-doped ceramics, it may also be possible that
the advantages of high porosities, such s good
permeability, might be counteracted by the deleterious
effects of wear particle release on cells. This question may
be clarifled by setting up a correlation between porosity
and biological response. This study indicates that the
porosity of the ceramics should be optimized to levels
where release of wear particles does not occur during use.
Figure 6:
Distribution of
viable cells on
undoped titanium
dioxide ceramic
visualized by
calcein-AM
fluorescent labe-
ling. Magn-
i cation χ 100.
Figure 7:
Distribution of
viable cells on
tungsten oxide-
doped samples.
Magni cation
xlOO.
Figure 8:
Distribution of
viable cells on
tantalum oxide-
doped samples.
Magni ca on
xlOO.
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